Roche Holding AG
RHHVF
Market Cap$27.63B
Close$
$526.43
125.7% upside
Current Fair Value
125.7% upsideUndervalued by 125.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $27.63 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $9.6 (0.0%) |
| Earnings per Share | $2.08 |
| Beta | 0.0 |
| Outstanding Shares | 702,562,700 |
| Avg 30 Day Volume | 19,085 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 12.3 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
ESG Score
No data
About Roche Holding AG
CEO: Severin Schwan Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ...